|
PART Ⅰ 1. American Diabetes Association (2013) Diagnosis and classification of diabetes mellitus. Diabetes care 36: S67–74 2. Marian AJ, Roberts R (1995) Recent advances in the molecular genetics of hypertrophic cardiomyopathy. Circulation 92 : 36–1347 3. Marian, A.J., Roberts, R. (1995) Recent advances in the molecular genetics of hypertrophic cardiomyopathy. Circulation, 92 , 36–1347 4. Boheler, K.R., Schwartz, K. (1992) Gene expression in cardiac hypertrophy. Trends Cardiovasc Med., 5 ,176–182 5. Boheler KR, Schwartz K (1992) Gene expression in cardiac hypertrophy. Trends Cardiovasc Med 5 : 176–182 6. Sugden, P.H., and Clerk, A. (1998) Cellular mechanisms of cardiac hypertrophy. J. Mol. Med., 76, 725–746 7. Colucci WS, and Braunwald E (1997) in Heart Disease (Braunwald, E., ed), 5th Ed., pp. 399-401 W. B. Saunders Co., Philadelphia, PA 8. Nag AC, Cheng M (1986) Biochemical evidence for cellular dedifferentiation in adult rat cardiac muscle cells in culture: expression of myosin isozymes. Biochem Biophys Res Commun 137 : 855–862 9. Eppenberger-Eberhardt M, Flamme I, Kurer V, Eppenberger HM (1990) Reexpression of alpha-smooth muscle actin isoform in cultured adult rat cardiomyocytes. Dev Biol 139 : 269–278 10. Eppenberger-Eberhardt M, Messerli M, Eppenberger HM, Reinecke M (1993) New occurrence of atrial natriuretic factor and storage in secretorially active granules in adult rat ventricular cardiomyocytes in long-term culture. J Mol Cell Cardiol 25 : 753–757 11.Seger R, Krebs EG (1995) The MAPK signaling cascade. Faseb J 9 : 726–735 12.Treisman R (1996) Regulation of transcription by map kinase cascades. Curr Opin Cell Biol 8 : 205–215 13.Cook JL, Bhandaru S, Giardian JF, Calycomb WC, Re RN (1995) Identification and antisense inhibition of a renin–angiotensin system in transgenic cardiomyocytes. Am J Physiol 268 : H1471–H1482 14.Sadoshima J, Xu Y, Slayter HS, Izumo S (1993) Autocrine release of angiotensin II mediates stretch-induced hypertrophy of cardiac myocytes in vitro. Cell 75 : 977–984. 15.Shubeita HE, McDonough PM, Harris AN et al (1990) Endothelin induction of inositol phospholipid hydrolysis, sarcomere assembly, and cardiac gene expression in ventricular myocytes. A paracrine mechanism for myocardial cell hypertrophy. J Biol Chem 265 : 20555–20562 16.Yamazaki T, Komuro I, Kudoh S et al (1996) Endothelin-1 is involved in mechanical stress-induced cardiomyocyte hypertrophy. J Biol Chem 271 : 3221–3228 17.Komuro I, Katoh Y, Kaida T et al (1991) Mechanical loading stimulates cell hypertrophy and specific gene expression in cultured rat cardiac myocytes. J Biol Chem 266 : 1265–1268 18.Kariya K, Karns LR, Simpson PC (1991) Expression of a constitutively activated mutant of the beta-isozyme of protein kinase C in cardiac myocytes stimulates the promoter of the beta-myosin heavy chain isogene. J Biol Chem 266 : 10023–10026 19.Yazaki Y, Komuro I, Yamazaki T et al (1993) Role of protein kinase system in the signal transduction of stretch-mediated protooncogene expression and hypertrophy of cardiac myocytes. Mol Cell Biochem 119 : 11–16 20.Molkentin JD, Lu J, Antos CL et al (1998) A calcineurin-dependent transcriptional pathway for cardiac hypertrophy. Cell 93 : 215–228 21.Sussman MA, Lim HW, Gude N et al (1998) Prevention of cardiac hypertrophy in mice by calcineurin inhibition. Science 281 : 1690–1693 22.Shimoyama M, Hayashi D, Takimoto E et al. Calcineurin plays a critical role in pressure overload-induced cardiac hypertrophy. Circulation 1999;100:2449–2454 23.Sturgill TW, Wu J (1991) Recent progress in characterization of protein kinase cascades for phosphorylation of ribosomal protein S6 (minireview). Biochim Biophys Acta 1092 : 350–357 24.Zheng C, Guan K (1994) Activation of MEK family kinases requires phosphorylation of two conserved ser / thr residues. EMBO J 13 : 1123–1131 25.Cobb MH, Robbins DJ, Boulton TG (1991) ERKs, extracellular signal-regulated MAP-2 kinases. Curr Opin Cell Biol 3 : 1025–1032 26.Sadoshima J, Qiu Z, Morgan JP, Izumo S (1995) Angiotensin II and other hypertrophic stimuli mediated by G protein-coupled receptors activate tyrosine kinase, mitogen-activated protein kinase, and 90-kD S6 kinase in cardiac myocytes. Circ Res 76 : 1–15 27.Clerk A, Sugden PH (1997) Cell stress-induced phosphorylation of ATF2 and c-jun transcription factors in rat ventricular myocytes. Biochem J 325 : 801–810 28.Wang Y, Huang S, Sah VP et al (1998) Cardiac muscle hypertrophy and apoptosis induced by distinct members of the p38 mitogen-actiwith vated protein kinase family. J Biol Chem 273 : 2161–2168 29.Schindler C, Darnell JEJ (1995) Transcriptional responses to polypeptide ligands: The JAK-STAT pathway (review). Annu Rev Biochem 64 : 621–651 30.Takahashi T, Fukuda K, Pan J et al (1999) Characterization of insulin-like growth factor-1-induced activation of the JAK/STAT pathway in rat cardiomyocytes. Circ Res 85 : 884–891 31.Mascareno E, Dhar M, Siddiqui MAQ (1998) Signal transduction and activator of transcription (STAT) protein-dependent activation of angiotensinogen promoter: a cellular signal for hypertrophy in cardiac muscle. Proc Natl Acad Sci USA 95: 5590–5594 32.Pan J, Fukuda K, Saito M et al (1999) Mechanical stretch activates the JAK/STAT pathway in rat cardiomyocytes. Circ Res 84 : 1127–1136 33.Hirota H,Chen J, Betz UA,Rajewsky K,Gu Y,et al.(1999)Loss of a gp130 cardiac muscle cell survival pathway is a critical event in the onset of heart failure during biomechanical stress. Cell, 97, 189-198 34.Rebekka L, Nicol Norbert, Frey, Gray, Pearson, Melanie, Cobb, James, Richardson, and Eric, N., Olson, (2001) Activated MEK5 induces serial assembly of sarcomeres and eccentric cardiac hypertrophy. EMBO J. 20, 2757-2767. 35.Zhou G, Bao ZQ and Dixon JE (1995) Components of a new human protein kinase signal transduction pathway. J. Biol. Chem., 270, 12665–12669. 36.English JM, Vanderbilt CA, Xu S, Marcus S and Cobb MH (1995) Isolation of MEK5 and differential expression of alternatively spliced forms. J. Biol. Chem., 270, 28897–28902. 37.Kato Y, Kravchenko VV, Tapping RI, Han J, Ulevitch RJ and Lee JD (1997) BMK1/ERK5 regulates serum-induced early gene expression through transcription factor MEF2C. EMBO J., 16, 7054–7066. 38.Fukuhara S, Marinissen MJ., Chiariello M and Gutkind JS (2000) Signaling from G protein-coupled receptors to ERK5/Big MAPK 1 involves G q and G 12/13 families of heterotrimeric G proteins. Evidence for the existence of a novel Ras and Rho-independent pathway. J. Biol. Chem., 275, 21730–21736. 39.Takeishi Y, Abe J, Lee JD, Kawakatsu H, Walsh RA and Berk BC(1999) Differential regulation of p90 ribosomal S6 kinase and big mitogen-activated protein kinase 1 by ischemia/reperfusion and oxidative stress in perfused guinea pig hearts. Circ. Res., 85, 1164–1172. 40.Kamakura S, Moriguchi T and Nishida E (1999) Activation of the protein kinase ERK5/BMK1 by receptor tyrosine kinases. Identification and characterization of a signaling pathway to the nucleus. J. Biol. Chem., 274, 26563–26571.
41.Silagy C, and Neil A (1994) Garlic as a lipid lowering agent-a meta-analysis. J R Coll Physicians Lond 28: 39-45 42.Amagase H, and Milner JA (1993) Impact of various sources of garlic and their constituents on 7,12-dimenthylbenz〔a〕anthracene binding to mammary cell DNA. Carcinogenesis 14: 1627-31 43.Jain RC, Vyas CR, Mahatma OP (1973) Hypoglycemic action of onion and garlic. Lancet 29: 1491 44.Manabe I, Shindo T, and Nagai R (2002) Gene expression in fibroblasts and fibrosis:involvement in cardiac hypertrophy. Circ Res 91:1103-1113 45.Schnee J M and Hsueh W A (2000) Angiotensin II, adhesion, and cardiac fibrosis. Cardiovasc Res 46:264-268 46.Krenz M, Robbins J (2004) Impact of beta-myosin heavy chain expression on cardiac function during stress. J Am Coll Cardiol. 44:2390-2397 47.Sambola Liekens E D C, Johan Neyts (2001) Angiogenesis:regulators and clinical application. Biochemical Phamacology 61:253-270 48.Morris C A, Avorn J (2003) Internet marketing of herbal products. JAMA 290:1505-1597 49.Blumenthal M(2003) Herbs continue slide in mainstream market:Sales down 14 percent. Herbal Gram 58,71. 50.Agarwal K (1996) Therapeutic actions of garlic constituents. Medicinal Res Rev 16:111-124. 51.Amagase H, Petesch BL, Matsuura H, Kasuga S, Itakura Y. (2001) Recent advances on the nutritional effects associated with the use of garlic as a supplement: intake of garlic and its bioactive components. J Nutr. 131(3):955S-962S. 52.Sheen LY,Lin SY and Tsai SJ (1992) Odor assessments for volatile compounds of garlic and ginger essential oil by sniffing method of gas chromatography. J Chin Agric Chem Soc. 30:14-24 53.Bordia A, Verma SK, Srivastava KC (1998) Effect of garlic (Allium sativum) on blood lipids, blood sugar, fibrinogen and fibrinolytic activity in patients with coronary artery disease. Prostaglandins Leukot Essent Fatty Acids. 58:257-63. 54.Banerjee SK, Maulik SK (2002) Effect of garlic on cardiovascular disorders: a review Nutr J. 1:4. 55.Keiss Hans-Peter, Verena M, Dirsch, Thomas H, Thomas H, Laurence T, Jacques A, Rémi K, and Angelika MV (2003) The American Society for Nutritional SciencesGarlic (Allium sativum L.) Modulates Cytokine Expression in Lipopolysaccharide-Activated Human Blood Thereby Inhibiting NF-κB Activity. J. Nutr. 133: 2171-2175 56. Augusti KT, Sheela CG (1996) Antiperoxide effect of S-allyl cysteine sulfoxide, an insulin secretagogue, in diabetic rats. Experientia 52:115-120. 57. Moriwaki H, Stempien-Otero A, Kremen M, Cozen AE, Dichek DA (2004) Overexpression of urokinase by macrophages or deficiency of plasminogen activator inhibitor type 1 causes cardiac fibrosis in mice. Circ Res. 95: 637–644. 58. Ghosh AK, Bradham WS, Gleaves LA, De Taeye B, Murphy SB, Covington JW, Vaughan DE (2010) Genetic deficiency of plasminogen activator inhibitor-1 promotes cardiac fibrosis in aged mice: involvement of constitutive transforming growth factor-beta signaling and endothelial-to-mesenchymal transition. Circulation. 122(12):1200-1209. PART Ⅱ 1. Sullivan PF, Kendler KS, Neale MC (2003) Schizophrenia as a complex trait: evidence from a meta-analysis of twin studies. Arch Gen Psychiatry 60:1187- 1192 2. Kendler KS, Gallagher TJ, Abelson JM, Kessler RC (1996) Lifetime prevalence, demographic risk factors, and diagnostic validity of nonaffective psychosis as assessed in a US community sample. The National Comorbidity Survey Arch Gen Psychiatry 53:1022-1031 3 Gallinat J, Bajbouj M, Sander T, Schlattmann P, Xu K, Ferro EF, Goldman D, Winterer G (2003) Association of the G1947A COMT (Val(108/158)Met) gene polymorphism with prefrontal P300 during information processing. Biol Psychiatry 54:40-48 4 Winterer G, Egan MF, Raedler T, Sanchez C, Jones DW, Coppola R, Weinberger DR (2003) P300 and genetic risk for schizophrenia. Arch Gen Psychiatry 60:1158-1167 5 Glahn DC, Therman S, Manninen M, Huttunen M, Kaprio J, Lonnqvist J, Cannon TD (2003) Spatial working memory as an endophenotype for schizophrenia. Biol Psychiatry 53:624-636 6 Fanous AH, Neale MC, Gardner C O, Webb BT, Straub RE, O’neill FA, Walsh D, Riley BP, Kendler KS (2007) Significant correlation in linkage signals from genome-wide scans of schizophrenia and schizotypy. Mol Psychiatry 12:958-965 7 Bechter K (2004) The mild encephalitis-hypothesis—new findings and studies. Psychiatr Prax 31:S41-43 8 Muller N, Schwarz M (2006) Schizophrenia as an inflammation-mediated dysbalance of glutamatergic neurotransmission. Neurotox Res 10:131-148 9 Schwarz MJ, Riedel M, Ackenheil M, Muller N (2000) Decreased levels of soluble intercellular adhesion molecule-1 (sICAM-1) in unmedicated and medicated schizophrenic patients. Biol Psychiatry 47:29-33 10 Avgustin B, Wraber B, Tavcar R(2005) Increased Th1 and Th2 immune reactivity with relative Th2 dominance in patients with acute exacerbation of schizophrenia. Croat Med J 46:268-274 11 Zhang XY, Zhou DF, Zhang PY, Wu GY, Cao LY, Shen YC (2002) Elevated interleukin-2, interleukin-6 and interleukin-8 serum levels in neuroleptic-free schizophrenia: association with psychopathology. Schizophr Res 57:247-258 12 Rudolf S, Peters M, Rothermundt M, Arolt V, Kirchner H. (2002) The influence of typical and atypical neuroleptic drugs in the production of interleukin-2 and interferon-gamma in vitro. Neuropsychobiology 46:180-185 13 Akhondzadeh S, Tabatabaee M, Amini H, Ahmadi Abhari SA, Abbasi SH, Behnam B (2007) Celecoxib as adjunctive therapy in schizophrenia: a double-blind, randomized and placebo-controlled trial. Schizophr Res 90:179-185 14 Kronfol Z, Remick DG (2000) Cytokines and the brain: implications for clinical psychiatry. Am J Psychiatry. 157:683-694 15 Maes M, Bosmans E, Calabrese J, Smith R, Meltzer HY (1995) Interleukin-2 and interleukin-6 in schizophrenia and mania: effects of neuroleptics and mood stabilizers. J Psychiatr Res. 29:141-152 16 Maes M, De, Meester I, Scharpe S, Desnyder R, Ranjan R, Meltzer HY (1996) Alterations in plasma dipeptidyl peptidase IV enzyme activity in depression and schizophrenia: effects of antidepressants and antipsychotic drugs. Acta Psychiatr Scand. 93(1):1-8 17 Tsai SY, Yang YY, Kuo CJ, Chen CC, Leu SJ (2001) Effects of symptomatic severity on elevation of plasma soluble interleukin-2 receptor in bipolar mania. J Affect Disord. 64(2-3):185-193 18 Smith RS (1992) A comprehensive marcophage-T-lymphocyte theory of schizophrenia. Med Hypoth 39: 248-257 19 Rapaport MH, Guylai L, Whybrow P (1999) Immune parameters in rapid cycling bipolar patients before and after lithium treatment. J Psychiatr Res. 33(4):335-340 20 Su KP, Leu SJC, Yang YY, Shen WW, Chou YM, Tsai SY (2002) Reduced production of interferon-gamma but not interleukin-10 in bipolar mania and subsequent remission. J Affect Disord 71: 205-209 21 O''Brien SM, Scully P, Scott LV, Dinan TG (2006) Cytokine profiles in bipolar affective disorder: focus on acutely ill patients. J Affect Disord. 90(2-3):263-267 22 Zimmer S, Pollard V, Marshall GD, Garofalo RP, Traber D, Prough D, Herndon DN The 1996 Moyer Award. Effects of endotoxin on the Th1/Th2 response in humans. J Burn Care Rehabil. 17(6 Pt 1):491-496. 23 Guay HM, Andreyeva TA, Garcea RL, Welsh RM, Szomolanyi-Tsuda E (2007) MyD88 Is Required for the Formation of Long-Term Humoral Immunity to Virus Infection. J Immunol. 178(8):5124-5131 24 Lehner M, Morhart P, Stilper A, Petermann D, Weller P, Stachel D, Holter W (2007) Efficient Chemokine-dependent Migration and Primary and Secondary IL-12 Secretion by Human Dendritic Cells Stimulated Through Toll-like Receptors. J Immunother. 30(3):312-322 25 Camateros P, Tamaoka M, Hassan M, Marino R, Moisan J, Marion D, Guiot MC, Martin JG, Radzioch D. (2007) Chronic Asthma Induced Airway Remodeling is Prevented by the Toll-like Receptor 7/8 Ligand S28463. Am J Respir Crit Care Med. 175(12):1241-1249 26 American Psychiatric Association, (1994) Diagnostic and Statistical Manual of Mental Disorders, 4th ed. American Psychiatric Association, Washington,DC. (DSM-IV). 27 AroltV, Rothermundt M, Peters M, Leonard B (2002) Immunological research in clinical psychiatry: report on the consensus debate during the 7th Expert Meeting on Psychiatry and Immunology. Mol. Psychiatry 7:822–826 28 Boey ML, Colaco CB,Gharavi AE, Elkon KB, Loizou S,Hughes GRV, (1983) Thrombosis in systemic lupus erythematosus: striking association with the presence of circulating lupus anticoagulant. Br. Med. J. 287:1021–1023 29 Canoso RT, deOliveira RM, Nixon RA, (1990) Neuroleptic-associated autoantibodies: a prevalence study. Biol. Psychiatry 27:863–870. 30 Chapman J, Cohen-Armon M, Shoenfeld Y, Korczyn AD, (1999) Antiphospholipid antibodies permeabilize and depolarize brain synaptoneurosomes. Lupus 8:127–133 31 Cimaz R, Meroni PL, Shoenfeld Y, (2006) Epilepsy as part of systemic lupus erythematosus and systemic antiphospholipid syndrome (Hughes syndrome). Lupus 15:191–197. 32 Matsumoto M, Funami K, Oshiumi H, Seya T., 2004. Toll-like receptor 3: a link between toll-like receptor, interferon and viruses. Microbiol Immunol. 48, 147-154. 33 Vercammen E, Staal J, Beyaert R (2008) Sensing of viral infection and activation of innate immunity by toll-like receptor 3. Clin Microbiol Rev. 21:13-25. 34 Smith KD, Ozinsky A (2002) Toll-like receptor-5 and the innate immune response to bacterial flagellin. Curr Top Microbiol Immunol. 270:93-108. 35 Rumbo M, Nempont C, Kraehenbuhl JP, Sirard JC, (2006) Mucosal interplay among commensal and pathogenic bacteria: lessons from flagellin and Toll-like receptor 5. FEBS Lett. 580:2976-2984.
|